Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
finasteride — steroid 5 alpha-reductase 2 Interaction
Drug-target interaction between finasteride and steroid 5 alpha-reductase 2. Synthetic organic pharmacological agent targeting this protein.
fingolimod — S1P1 receptor Interaction
Drug-target interaction between fingolimod and S1P1 receptor. Synthetic organic pharmacological agent targeting this protein.
fingolimod — S1P5 receptor Interaction
Drug-target interaction between fingolimod and S1P5 receptor. Synthetic organic pharmacological agent targeting this protein.
finotonlimab — programmed cell death 1 (CD279) Interaction
Drug-target interaction between finotonlimab and programmed cell death 1 (CD279). Antibody pharmacological agent targeting this protein.
flibanserin — 5-HT1A receptor Interaction
Drug-target interaction between flibanserin and 5-HT1A receptor. Synthetic organic pharmacological agent targeting this protein.
flibanserin — 5-HT2A receptor Interaction
Drug-target interaction between flibanserin and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
fludarabine — ribonucleotide reductase catalytic subunit M1 Interaction
Drug-target interaction between fludarabine and ribonucleotide reductase catalytic subunit M1. Synthetic organic pharmacological agent targeting this protein.
fludarabine — ribonucleotide reductase regulatory subunit M2 Interaction
Drug-target interaction between fludarabine and ribonucleotide reductase regulatory subunit M2. Synthetic organic pharmacological agent targeting this protein.
fludrocortisone — Mineralocorticoid receptor Interaction
Drug-target interaction between fludrocortisone and Mineralocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
flumazenil — GABAA receptor α1 subunit Interaction
Drug-target interaction between flumazenil and GABAA receptor α1 subunit. Synthetic organic pharmacological agent targeting this protein.
flumazenil — GABAA receptor α2 subunit Interaction
Drug-target interaction between flumazenil and GABAA receptor α2 subunit. Synthetic organic pharmacological agent targeting this protein.
flumazenil — GABAA receptor α3 subunit Interaction
Drug-target interaction between flumazenil and GABAA receptor α3 subunit. Synthetic organic pharmacological agent targeting this protein.
flumazenil — GABAA receptor α5 subunit Interaction
Drug-target interaction between flumazenil and GABAA receptor α5 subunit. Synthetic organic pharmacological agent targeting this protein.
flunisolide — Glucocorticoid receptor Interaction
Drug-target interaction between flunisolide and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
flunitrazepam — GABAA receptor α1 subunit Interaction
Drug-target interaction between flunitrazepam and GABAA receptor α1 subunit. Synthetic organic pharmacological agent targeting this protein.
flunitrazepam — GABAA receptor α2 subunit Interaction
Drug-target interaction between flunitrazepam and GABAA receptor α2 subunit. Synthetic organic pharmacological agent targeting this protein.
flunitrazepam — GABAA receptor α3 subunit Interaction
Drug-target interaction between flunitrazepam and GABAA receptor α3 subunit. Synthetic organic pharmacological agent targeting this protein.
flunitrazepam — GABAA receptor α5 subunit Interaction
Drug-target interaction between flunitrazepam and GABAA receptor α5 subunit. Synthetic organic pharmacological agent targeting this protein.
fluocinolone acetonide — Glucocorticoid receptor Interaction
Drug-target interaction between fluocinolone acetonide and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
fluocinonide — Glucocorticoid receptor Interaction
Drug-target interaction between fluocinonide and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
fluorometholone — Glucocorticoid receptor Interaction
Drug-target interaction between fluorometholone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
fluoxetine — SERT Interaction
Drug-target interaction between fluoxetine and SERT. Synthetic organic pharmacological agent targeting this protein.
fluoxymesterone — Androgen receptor Interaction
Drug-target interaction between fluoxymesterone and Androgen receptor. Synthetic organic pharmacological agent targeting this protein.
flupentixol — D1 receptor Interaction
Drug-target interaction between flupentixol and D1 receptor. Synthetic organic pharmacological agent targeting this protein.
flupentixol — D2 receptor Interaction
Drug-target interaction between flupentixol and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
fluphenazine — D2 receptor Interaction
Drug-target interaction between fluphenazine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
flurbiprofen — COX-1 Interaction
Drug-target interaction between flurbiprofen and COX-1. Synthetic organic pharmacological agent targeting this protein.
flurbiprofen — COX-2 Interaction
Drug-target interaction between flurbiprofen and COX-2. Synthetic organic pharmacological agent targeting this protein.
flutamide — Androgen receptor Interaction
Drug-target interaction between flutamide and Androgen receptor. Synthetic organic pharmacological agent targeting this protein.
fluticasone — Glucocorticoid receptor Interaction
Drug-target interaction between fluticasone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
fluticasone propionate — Glucocorticoid receptor Interaction
Drug-target interaction between fluticasone propionate and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
fluvastatin — hydroxymethylglutaryl-CoA reductase Interaction
Drug-target interaction between fluvastatin and hydroxymethylglutaryl-CoA reductase. Synthetic organic pharmacological agent targeting this protein.
fluvoxamine — SERT Interaction
Drug-target interaction between fluvoxamine and SERT. Synthetic organic pharmacological agent targeting this protein.
fondaparinux — serpin family C member 1 Interaction
Drug-target interaction between fondaparinux and serpin family C member 1. Synthetic organic pharmacological agent targeting this protein.
Food-Drug Interactions
Food can significantly affect drug absorption, metabolism, and efficacy. Understanding food-drug interactions is essential for optimizing drug therapy.
formoterol — β2-adrenoceptor Interaction
Drug-target interaction between formoterol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
fosinopril — Angiotensin-converting enzyme Interaction
Drug-target interaction between fosinopril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
frovatriptan — 5-HT1B receptor Interaction
Drug-target interaction between frovatriptan and 5-HT1B receptor. Synthetic organic pharmacological agent targeting this protein.
frovatriptan — 5-HT1D receptor Interaction
Drug-target interaction between frovatriptan and 5-HT1D receptor. Synthetic organic pharmacological agent targeting this protein.
fruquintinib — fms related receptor tyrosine kinase 1 Interaction
Drug-target interaction between fruquintinib and fms related receptor tyrosine kinase 1. Synthetic organic pharmacological agent targeting this protein.
fruquintinib — fms related receptor tyrosine kinase 4 Interaction
Drug-target interaction between fruquintinib and fms related receptor tyrosine kinase 4. Synthetic organic pharmacological agent targeting this protein.
fruquintinib — kinase insert domain receptor Interaction
Drug-target interaction between fruquintinib and kinase insert domain receptor. Synthetic organic pharmacological agent targeting this protein.
FSH — FSH receptor Interaction
Drug-target interaction between FSH and FSH receptor. Peptide pharmacological agent targeting this protein.
fulvestrant — Estrogen receptor-α Interaction
Drug-target interaction between fulvestrant and Estrogen receptor-α. Synthetic organic pharmacological agent targeting this protein.
fulvestrant — Estrogen receptor-β Interaction
Drug-target interaction between fulvestrant and Estrogen receptor-β. Synthetic organic pharmacological agent targeting this protein.
furosemide — Kidney-specific Na-K-Cl symporter Interaction
Drug-target interaction between furosemide and Kidney-specific Na-K-Cl symporter. Synthetic organic pharmacological agent targeting this protein.
gabexate — tryptase alpha/beta 1 Interaction
Drug-target interaction between gabexate and tryptase alpha/beta 1. Synthetic organic pharmacological agent targeting this protein.
garsorasib — KRAS Interaction
Drug-target interaction between garsorasib and KRAS. Synthetic organic pharmacological agent targeting this protein.
gefitinib — epidermal growth factor receptor Interaction
Drug-target interaction between gefitinib and epidermal growth factor receptor. Synthetic organic pharmacological agent targeting this protein.
gemcitabine — ribonucleotide reductase catalytic subunit M1 Interaction
Drug-target interaction between gemcitabine and ribonucleotide reductase catalytic subunit M1. Synthetic organic pharmacological agent targeting this protein.
gemcitabine — ribonucleotide reductase regulatory subunit M2 Interaction
Drug-target interaction between gemcitabine and ribonucleotide reductase regulatory subunit M2. Synthetic organic pharmacological agent targeting this protein.
gemfibrozil — Peroxisome proliferator-activated receptor-α Interaction
Drug-target interaction between gemfibrozil and Peroxisome proliferator-activated receptor-α. Synthetic organic pharmacological agent targeting this protein.
gemtuzumab ozogamicin — CD33 Interaction
Drug-target interaction between gemtuzumab ozogamicin and CD33. Antibody pharmacological agent targeting this protein.
glasdegib — SMO Interaction
Drug-target interaction between glasdegib and SMO. Synthetic organic pharmacological agent targeting this protein.
glibenclamide — Kir6.2 Interaction
Drug-target interaction between glibenclamide and Kir6.2. Synthetic organic pharmacological agent targeting this protein.
glucagon — glucagon receptor Interaction
Drug-target interaction between glucagon and glucagon receptor. Peptide pharmacological agent targeting this protein.
glycopyrrolate — M1 receptor Interaction
Drug-target interaction between glycopyrrolate and M1 receptor. Synthetic organic pharmacological agent targeting this protein.
glycopyrrolate — M2 receptor Interaction
Drug-target interaction between glycopyrrolate and M2 receptor. Synthetic organic pharmacological agent targeting this protein.
glycopyrrolate — M3 receptor Interaction
Drug-target interaction between glycopyrrolate and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
glycopyrrolate — M4 receptor Interaction
Drug-target interaction between glycopyrrolate and M4 receptor. Synthetic organic pharmacological agent targeting this protein.